In this model, mice develop multiple GDM-like symptoms during pregnancy, including glucose intolerance upon glucose challenge (Fig. 1b), decreased serum insulin paired with lower total beta cells, insulin resistance, and maternal dyslipidemia by embryonic day 13.5 (E13.5)40–42. This evidence concerns the gene INS and metabolic syndrome.